Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy — Stella

Home/Membranous Nephropathy - PLA2R Induced/

View on ClinicalTrials.gov

Recruiting

Back to Membranous Nephropathy - PLA2R Induced trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Russia

St. Petersburg State Pavlov Medical University, Saint Petersburg

Key details

Sponsor

St. Petersburg State Pavlov Medical University

Enrollment target

~40 participants

Started

May 2018

Primary completion

August 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.